AMPICLOX is indicated for the treatment of the following infections including mixed Gram-positive (except methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococcus (MRCoNS)) and Gram-negative infections: -Surgery: post-operative wound infections post-operative pulmonary infections. -Respiratory infections: bronchopneumonia acute exacerbations of chronic bronchitis. -Obstetrics: puerperal fever. -Other infections such as septicaemia bone infections e.g. osteomyelitis ear nose and throatinfections. Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to Ampixclox.